“What we have here, I believe, is a strong signal that there is a population…who will benefit from chemotherapy,” said Mark D. Hurwitz, MD, FASTRO, FACRO. Nitin Ohri, MD, MS, explains the rationale ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results